# Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation

> **NCT01168167** · — · COMPLETED · sponsor: **Christoph Stephan** · enrollment: 20 (actual)

## Conditions studied

- HIV-1

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01168167
- **Lead sponsor:** Christoph Stephan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-03
- **Final completion:** 2012-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01168167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01168167, "Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01168167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*